Reduced microvascular perfusion and reactivity in adult GH deficient patients is restored by GH replacement
The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Abstract
BACKGROUND: An increased cardiovascular risk and mortality in hypopituitary patients receiving conventional hormonal treatment without GH replacement have been shown in several studies. Various atherogenic risk factors including endothelial dysfunction - an early event in the atherogenesis - are more expressed in adults with GH-deficiency (GHD). Changes in microcirculation and vascular reactivity could represent an early marker of developing vascular changes. OBJECTIVE: To evaluate the microcirculation and vascular reactivity in a GHD state before and during GH replacement. SUBJECTS, METHODS AND DESIGN: Thirteen adult patients (ten men, mean age 40+/-9 years) with severe GHD were studied. The skin microvascular perfusion and reactivity were measured by laser-Doppler flowmetry on the forearm. Two dynamic tests for vascular perfusion and reactivity were used - postocclusive reactive hyperemia (PORH) and thermal hyperemia (TH) at 44 degrees C. Measurements were performed before and after 6 and 12 months on GH replacement with a dose of GH that normalized IGF-I serum levels. The parameters of tissue perfusion and vascular reactivity measured in GHD were compared with values during GH treatment and with the results of the control group. RESULTS: Peak flow during TH in GHD patients was significantly reduced before GH treatment when compared with healthy subjects (means+/-s.e.m., 68+/-6.6 vs 111+/-8.3 perfusion units (PU), P<0.001) and normalized on GH treatment (109+/-12.7 PU). The velocity of perfusion increase during TH before treatment was significantly reduced in GHD as well (0.84+/-0.07 vs 1.53+/-0.19 PU/s, P<0.03) and normalized on GH treatment (1.38+/-0.24 PU/s). The PORH was also significantly reduced in GHD compared with controls (PORH(max) 414+/-63 vs 528+/-58%, P<0.05) and during GH treatment was restored to values not different from controls (642+/-86%, P=NS). CONCLUSIONS: Skin microcirculation and vascular reactivity measured by laser-Doppler flowmetry is significantly reduced in GHD adults and is restored during GH replacement therapy. Reduced tissue perfusion and reactivity probably reflect the endothelial dysfunction in the GHD state. Reduced nitric oxide production and bioavailability and also other factors like increased sympathetic activity and reduced conversion of thyroxine to triiodothyronine in the GHD state can contribute to changes in microcirculation. Restoration of vascular reactivity by GH replacement might have favorable clinical consequences on the increased vascular morbidity of GHD patients. Reduced skin microvascular perfusion and reactivity in GHD probably contribute to the impaired thermoregulation - a clinical symptom of GHD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“most of the pituitary hormones have been shown to have important cerebral effects that impact not only brain development, but also allow normal brain function and are integral for effective brain repair and recovery.”
From Chapter 1: pathophysiology of hypopituitarism in the setting of brain injury (2012) · cites this paper as [48]
In the citing paper
“it is now clear that there are both GH and insulinlike growth factor (IGF-1) receptors widely present in the brain.”
From Chapter 1: pathophysiology of hypopituitarism in the setting of brain injury (2012) · cites this paper as [48]
In the citing paper
“GH has been shown to be directly involved in vascular reactivity, vascular tone and CNS repair processes after hypoxic injury”
From Chapter 1: pathophysiology of hypopituitarism in the setting of brain injury (2012) · cites this paper as [48]
In the citing paper
“IGF-1 appears to be an important factor in myelination, re-myelination, prevention of demyelination and protection of oligodendrocytes from tumor necrosis factor-α induced apoptosis [47–56].”
From Chapter 1: pathophysiology of hypopituitarism in the setting of brain injury (2012) · cites this paper as [48]
Citations
Cites
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
Celermajer, D. S., Sorensen, K. E., Gooch, V. M., Spiegelhalter, D. J., Miller, O. I., Sullivan, I. D., Lloyd, J. K., & Deanfield, J. E. (1992) · The Lancet · doi:10.1016/0140-6736(92)93147-f · Cited by 4,742 · cited 1×
“Results of FMD induced by shear stress are known to be dependent on endothelium-derived production of nitric oxide (NO) ( 11 ).”
BackgroundPremature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402 · cited 1×
“Some of these studies documented an increased vascular mortality ( 1 , 4, 5), although some did not (2, 3, 6). Changes in various atherogenic risk factors have been demonstrated in growth hormone (GH) deficiency (GHD) ‐ lipids, coagulation factors, insulin resistance, blood pressure, enhanced oxidative stress, cardiac…”
BackgroundAssociation between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study1
Orme, S. M., McNally, R. J. Q., Cartwright, R. A., & Belchetz, P. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5007 · Cited by 805
Increased cerebrovascular mortality in patients with hypopituitarism
Bülow, B., Hagmar, L., Mikoczy, Z., Nordström, C., & Erfurth, E. M. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.d01-1749.x · Cited by 542
The effect of hypopituitarism on life expectancy.
Bates, A. S., Van't Hoff, W., Jones, P. J., & Clayton, R. N. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772595 · Cited by 475 · cited 1×
“Some of these studies documented an increased vascular mortality (1, 4, 5), although some did not ( 2 , 3, 6). Changes in various atherogenic risk factors have been demonstrated in growth hormone (GH) deficiency (GHD) ‐ lipids, coagulation factors, insulin resistance, blood pressure, enhanced oxidative stress, cardiac…”
BackgroundBöger, R. H., Skamira, C., Bode-Böger, S. M., Brabant, G., von zur Muhlen, A., & Frolich, J. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119095 · Cited by 270
Growth Hormone (GH) Treatment Reverses Early Atherosclerotic Changes in GH-Deficient Adults1
Pfeifer, M., Verhovec, R., Zizek, B., Prezelj, J., Poredos, P., & Clayton, R. N. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5456 · Cited by 260
JøRGENSEN, J. O. L., PEDERSEN, S. A., LAURBERG, P., WEEKE, J., SKAKKEBÆK, N. E., & CHRISTIANSEN, J. S. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-6-1127 · Cited by 192 · cited 1×
“GH replacement stimulates peripheral conversion of thyroxine (T4) to the active hormone triiodothyronine (T3 )i n GHD adult patients ( 16 ).”
BackgroundPituitary Adenomas in Sweden between 1958 and 1991: Incidence, Survival, and Mortality1
Nilsson, B., Gustavsson-Kadaka, E., Bengtsson, B.-Å., & Jonsson, B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6498 · Cited by 151
Cited by
Kelly, D. F., McArthur, D. L., Levin, H., Swimmer, S., Dusick, J. R., Cohan, P., Wang, C., & Swerdloff, R. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.928 · Cited by 158
Chapter 1: pathophysiology of hypopituitarism in the setting of brain injury
Dusick, J. R., Wang, C., Cohan, P., Swerdloff, R., & Kelly, D. F. (2012) · Pituitary · doi:10.1007/s11102-008-0130-6 · Cited by 121
Acute gonadotroph and somatotroph hormonal suppression after traumatic brain injury
Wagner, J., Dusick, J. R., McArthur, D. L., Cohan, P., Wang, C., Swerdloff, R., Boscardin, W. J., & Kelly, D. F. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2009.1092 · Cited by 69
Colao, A., Di Somma, C., Rota, F., Pivonello, R., Savanelli, M. C., Spiezia, S., & Lombardi, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2247 · Cited by 62
Ethnic differences in skin microvascular function and their relation to cardiac target-organ damage
Strain, W. D., Chaturvedi, N., Leggetter, S., Nihoyannopoulos, P., Rajkumar, C., Bulpitt, C. J., & Shore, A. C. (2005) · Journal of Hypertension · doi:10.1097/00004872-200501000-00023 · Cited by 47
Metadata
- Authors
- Hana, V, Prazny, M., Marek, J., Skrha, J., & Justova, V
- Affiliations
- Charles University (CZ)
- ORCID
- Marek, J
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-09-01
- Volume
- 147
- Issue
- 3
- Pages
- 333-337
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2143643540
- Cited by
- 23
- References
- 21
- Citations by year
- 2024: 2 · 2020: 1 · 2016: 1 · 2013: 2
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- growth hormone deficiency, growth hormone replacement therapy, skin microcirculation, microvascular blood flow, vascular reactivity, endothelial dysfunction, post-occlusive reactive hyperemia, nitric oxide, cardiovascular risk, hypopituitarism, IGF-I normalization, laser Doppler flowmetry
- MeSH terms
- Adult, Arteriosclerosis, Constriction, Endothelium, Vascular, Female, Forearm, Hot Temperature, Humans, Hyperemia, Hypopituitarism, Insulin-Like Growth Factor I, Male, Microcirculation, Middle Aged, Risk Factors, Skin, Laser-Doppler Flowmetry, Human Growth Hormone, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduced microvascular perfusion and reactivity in adult GH deficient patients is restored by GH replacement. https://app.cochat.ai/papers/10.1530/eje.0.1470333
- The paper
- Hana, V, Prazny, M., Marek, J., Skrha, J., & Justova, V. (2002). Reduced microvascular perfusion and reactivity in adult GH deficient patients is restored by GH replacement. European Journal of Endocrinology. https://doi.org/10.1530/eje.0.1470333
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.